These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7018522)

  • 21. Refinement in the measurement of treatment response with combined L-dopa and amantadine in Parkinsonism.
    Kravitz EA; Hollmann TD
    J Chronic Dis; 1974 Dec; 27(11-12):563-72. PubMed ID: 4612055
    [No Abstract]   [Full Text] [Related]  

  • 22. An extended clinical trial to compare levodopa and amantadine used as single drugs with both drugs used incombination in Parkinson's Disease.
    Calaghan N; McIlroy M; O'Connor M
    Ir J Med Sci; 1974 Mar; 143(2):79-85. PubMed ID: 4617745
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current drug treatment of parkinsonism].
    Kistenev BA; Kadykov AS; Pivovarova VM
    Sov Med; 1976 Nov; (11):57-61. PubMed ID: 1006394
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents].
    Gospavić J; Vidaković Z
    Srp Arh Celok Lek; 1974 Jun; 102(6):447-57. PubMed ID: 4450143
    [No Abstract]   [Full Text] [Related]  

  • 25. [The use of Stalevo in Hungary for patients with Parkinson disease and its effect on the quality of life].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2008 Jan; 61(1-2):42-8. PubMed ID: 18372774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Amantadine for the treatment of levodopa dyskinesias in Parkinson's disease].
    Cersósimo MG; Scorticati MC; Micheli FE
    Medicina (B Aires); 2000; 60(3):321-5. PubMed ID: 11050808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of intravenous administration of memantine in parkinsonian patients (author's transl)].
    Fischer PA; Jacobi P; Schneider E; Schönberger B
    Arzneimittelforschung; 1977 Jul; 27(7):1487-9. PubMed ID: 332193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twenty-five years of amantadine therapy in Parkinson's disease.
    Danielczyk W
    J Neural Transm Suppl; 1995; 46():399-405. PubMed ID: 8821075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term bromocriptine treatment in de novo parkinsonian patients.
    Herskovits E; Yorio A; Leston J
    Medicina (B Aires); 1988; 48(4):345-50. PubMed ID: 3076200
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical significance of pyridoxine administration in L-dopa therapy of Parkinsonism (author's transl)].
    Namba S; Ishimitsu H; Nakasone S
    No To Shinkei; 1980 Oct; 32(10):991-1000. PubMed ID: 6159908
    [No Abstract]   [Full Text] [Related]  

  • 31. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Ulm G
    Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
    [No Abstract]   [Full Text] [Related]  

  • 32. Piribedil (ET 495) in the treatment of Parkinson's disease combined with amantadine or levodopa.
    Callaghan N; Fitzpatrick E; O'Mahony JB
    Acta Neurol Scand; 1975 Sep; 52(3):179-86. PubMed ID: 1098359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Multivariate analysis of the problems of long-term levodopa therapy in Parkinson's disease].
    Nakamura Y; Yoshinaga J; Endo S; Hikiji A
    Rinsho Shinkeigaku; 1997 Jun; 37(6):469-75. PubMed ID: 9366172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
    [No Abstract]   [Full Text] [Related]  

  • 35. [Amantadine and dexetimide in the treatment of parkinsonism].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
    [No Abstract]   [Full Text] [Related]  

  • 36. [L-dopa-induced movement disorders in Parkinson disease. Amantadine improves dyskinesia].
    MMW Fortschr Med; 2001 May; 143 Suppl 2():93. PubMed ID: 11434272
    [No Abstract]   [Full Text] [Related]  

  • 37. [Amandatine hydrochloride (Symmetrel) in the treatment of parkinsonism].
    Nikolić M; Lević Z
    Srp Arh Celok Lek; 1976 Feb; 104(2):113-8. PubMed ID: 1013802
    [No Abstract]   [Full Text] [Related]  

  • 38. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 39. Amantadine hydrochloride in the treatment of Parkinson's disease.
    Nagaswami S; Ranjini R
    J Kans Med Soc; 1971 Nov; 72(11):465-8. PubMed ID: 5120698
    [No Abstract]   [Full Text] [Related]  

  • 40. Amantadine-induced "vocal" myoclonus.
    Pfeiffer RF
    Mov Disord; 1996 Jan; 11(1):104-6. PubMed ID: 8771080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.